Data from Investigational Device Exemption (IDE) study in Roux-en-Y gastric bypass procedures used to support application for De Novo classification Second IDE approved for U.S. clinical trial for ...
NEW BRUNSWICK, N.J., April 14, 2025 /PRNewswire/ -- Johnson & Johnson MedTech, a global leader in surgical technologies and solutions, today announced completion of the first cases in the clinical ...
(RTTNews) - Johnson & Johnson (JNJ), Wednesday announced the submission of an application to the U.S. Food and Drug Administration, seeking De Novo classification for OTTAVA Robotic Surgical System, a ...
Johnson & Johnson (JNJ) just made a move that investors have been waiting years to see. The healthcare heavyweight submitted its OTTAVA robotic surgical system to the FDA for De Novo classification.
The global surgical robot market was valued at about $4.3 billion in 2024 and is expected to reach approximately $7.4 billion by 2030, according to market research firm Grand View Research. The North ...
NEW BRUNSWICK, N.J., April 14, 2025 /PRNewswire/ -- Johnson & Johnson MedTech, a global leader in surgical technologies and solutions, today announced completion of the first cases in the clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results